314 related articles for article (PubMed ID: 11355922)
1. Clinical importance of cytogenetics in acute myeloid leukaemia.
Mrózek K; Heinonen K; Bloomfield CD
Best Pract Res Clin Haematol; 2001 Mar; 14(1):19-47. PubMed ID: 11355922
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of cytogenetics in acute myeloid leukemia.
Mrózek K; Heinonen K; de la Chapelle A; Bloomfield CD
Semin Oncol; 1997 Feb; 24(1):17-31. PubMed ID: 9045301
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of acute myeloblastic leukemia according to the new WHO classification: a different distribution in Central-West Spain.
Chillón CM; García-Sanz R; Balanzategui A; Ramos F; Fernández-Calvo J; Rodríguez MJ; Rodríguez-Salazar MI; Corrales A; Calmuntia MJ; Orfão A; González M; San Miguel JF
Haematologica; 2001 Feb; 86(2):162-6. PubMed ID: 11224485
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of cytogenetic findings in adults with acute myeloid leukemia.
Mrózek K; Heinonen K; Bloomfield CD
Int J Hematol; 2000 Oct; 72(3):261-71. PubMed ID: 11185980
[TBL] [Abstract][Full Text] [Related]
5. The influence of age on prognosis of de novo acute myeloid leukemia differs according to cytogenetic subgroups.
Schoch C; Kern W; Schnittger S; Büchner T; Hiddemann W; Haferlach T
Haematologica; 2004 Sep; 89(9):1082-90. PubMed ID: 15377469
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetics in acute leukemia.
Mrózek K; Heerema NA; Bloomfield CD
Blood Rev; 2004 Jun; 18(2):115-36. PubMed ID: 15010150
[TBL] [Abstract][Full Text] [Related]
7. A new prognostic score for patients with acute myeloid leukemia based on cytogenetics and early blast clearance in trials of the German AML Cooperative Group.
Haferlach T; Kern W; Schoch C; Schnittger S; Sauerland MC; Heinecke A; Büchner T; Hiddemann W;
Haematologica; 2004 Apr; 89(4):408-18. PubMed ID: 15075074
[TBL] [Abstract][Full Text] [Related]
8. Therapy-related myeloid leukaemia: a model for leukemogenesis in humans.
Larson RA; Le Beau MM
Chem Biol Interact; 2005 May; 153-154():187-95. PubMed ID: 15935816
[TBL] [Abstract][Full Text] [Related]
9. New insights into the biology of acute myeloid leukemia and their impact on treatment.
Hiddemann W; Haferlach T; Schoch C; Behre G; Kohlmann A; Kern W; Feuring-Buske M; Bohlander S
Verh Dtsch Ges Pathol; 2003; 87():72-8. PubMed ID: 16888897
[TBL] [Abstract][Full Text] [Related]
10. Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia?
Larson RA
Best Pract Res Clin Haematol; 2007 Mar; 20(1):29-37. PubMed ID: 17336252
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of acute myeloid leukemia classification. Importance of detection of recurring cytogenetic abnormalities and multilineage dysplasia on survival.
Arber DA; Stein AS; Carter NH; Ikle D; Forman SJ; Slovak ML
Am J Clin Pathol; 2003 May; 119(5):672-80. PubMed ID: 12760285
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and cytogenetics studies on acute myeloid leukemia with abnormality of chromosome 11].
Lu Y; Xu W; Chen Z; Lou J; Jin J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):583-5. PubMed ID: 18841578
[TBL] [Abstract][Full Text] [Related]
13. Genetic classification of acute myeloid leukemia (AML).
Haferlach T; Schnittger S; Kern W; Hiddemann W; Schoch C
Ann Hematol; 2004; 83 Suppl 1():S97-100. PubMed ID: 15124693
[TBL] [Abstract][Full Text] [Related]
14. Detection of the CBFB/MYH11 fusion gene in de novo acute myeloid leukemia (AML): a single-institution study of 224 Japanese AML patients.
Monma F; Nishii K; Shiga J; Sugahara H; Lorenzo F; Watanabe Y; Kawakami K; Hosokai N; Yamamori S; Katayama N; Shiku H
Leuk Res; 2007 Apr; 31(4):471-6. PubMed ID: 17052753
[TBL] [Abstract][Full Text] [Related]
15. Chromosome aberrations in de novo acute myeloid leukemia patients in Kuwait.
Al Bahar S; Pandita R; Bavishi K; Kreze O; Nath S
Neoplasma; 2004; 51(3):223-7. PubMed ID: 15254677
[TBL] [Abstract][Full Text] [Related]
16. Childhood myeloid leukaemias.
Hall GW
Best Pract Res Clin Haematol; 2001 Sep; 14(3):573-91. PubMed ID: 11640870
[TBL] [Abstract][Full Text] [Related]
17. The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia.
Grimwade D
Best Pract Res Clin Haematol; 2001 Sep; 14(3):497-529. PubMed ID: 11640867
[TBL] [Abstract][Full Text] [Related]
18. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.
Schoch C; Haferlach T; Bursch S; Gerstner D; Schnittger S; Dugas M; Kern W; Löffler H; Hiddemann W
Genes Chromosomes Cancer; 2002 Sep; 35(1):20-9. PubMed ID: 12203786
[TBL] [Abstract][Full Text] [Related]
19. Molecular biology of acute myeloid leukemia.
Caligiuri MA; Strout MP; Gilliland DG
Semin Oncol; 1997 Feb; 24(1):32-44. PubMed ID: 9045303
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of cytogenetic aberrations in childhood acute myeloid leukaemia. A study of the Swiss Paediatric Oncology Group (SPOG).
Betts DR; Ammann RA; Hirt A; Hengartner H; Beck-Popovic M; Kuhne T; Nobile L; Caflisch U; Wacker P; Niggli FK
Eur J Haematol; 2007 Jun; 78(6):468-76. PubMed ID: 17419750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]